Alzheimer’s Breakthrough Is Boost for Biogen, Eli Lilly Despite Side-Effect Concerns

Alzheimer’s Breakthrough Is Boost for Biogen, Eli Lilly Despite Side-Effect Concerns

Shares in pharmaceutical companies rose after the publication of a paper detailing the apparent benefits of the lecanemab drug.